Stockreport

IO Biotech Announces Participation in Upcoming Investor Conferences

IO Biotech, Inc.  (IOBT) 
PDF NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cance [Read more]